Science 37 Receives Top Honors in Everest PEAK Matrix®
RESEARCH TRIANGLE PARK, N.C., Dec. 12, 2023 (GLOBE NEWSWIRE) — Science 37 Holdings, Inc. (Nasdaq:SNCE), the clinical research industry-leading Metasite™ today announced that it has been named a Leader in the Decentralized Clinical Trials (DCT) PEAK Matrix® Assessment by the Everest Group, for the third consecutive year.
Related news for (SNCE)
- INVESTIGATION ALERT: Halper Sadeh LLC Investigates MGRC, SNCE, VINE, CALB
- SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates MGRC, SNCE, VINE, CERE
- Science 37 to be Acquired by eMed, Expanding Access to Patients and Accelerating Enrollment
- Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)